Statistics for Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzyl-guanidine (MIBG) therapy in metastatic paediatric paragan-glioma: observation of false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy
Total visits
| views | |
|---|---|
| Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzyl-guanidine (MIBG) therapy in metastatic paediatric paragan-glioma: observation of false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy | 0 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |